Organogenesis Holdings, Inc. (ORGO)
1.75
+0.08
(+4.79%)
USD |
NASDAQ |
Aug 25, 11:56
Organogenesis Holdings Shareholders Equity (Quarterly) : 288.13M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 288.13M |
| March 31, 2026 | 381.35M |
| December 31, 2025 | 433.92M |
| September 30, 2025 | 385.98M |
| June 30, 2025 | 361.22M |
| March 31, 2025 | 368.07M |
| December 31, 2024 | 385.32M |
| September 30, 2024 | 278.55M |
| June 30, 2024 | 263.50M |
| March 31, 2024 | 278.03M |
| December 31, 2023 | 278.66M |
| September 30, 2023 | 276.86M |
| June 30, 2023 | 271.28M |
| March 31, 2023 | 263.70M |
| December 31, 2022 | 265.67M |
| September 30, 2022 | 256.33M |
| June 30, 2022 | 254.38M |
| March 31, 2022 | 243.23M |
| December 31, 2021 | 241.34M |
| September 30, 2021 | 189.17M |
| Date | Value |
|---|---|
| June 30, 2021 | 178.92M |
| March 31, 2021 | 157.29M |
| December 31, 2020 | 141.81M |
| September 30, 2020 | 65.47M |
| June 30, 2020 | 35.75M |
| March 31, 2020 | 40.30M |
| December 31, 2019 | 55.58M |
| September 30, 2019 | 12.81M |
| June 30, 2019 | 23.20M |
| March 31, 2019 | 32.56M |
| December 31, 2018 | 47.04M |
| September 30, 2018 | 303.17M |
| June 30, 2018 | 298.24M |
| March 31, 2018 | 297.88M |
| December 31, 2017 | 298.01M |
| September 30, 2017 | 298.51M |
| June 30, 2017 | 300.63M |
| March 31, 2017 | 300.25M |
| December 31, 2016 | 300.11M |
| September 30, 2016 | -0.0307M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| cbdMD, Inc. | 8.212M |
| Guardian Pharmacy Services, Inc. | 245.61M |
| Ironwood Pharmaceuticals, Inc. | -161.84M |
| Verastem, Inc. | 49.99M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 406.45M |
| Total Liabilities (Quarterly) | 118.31M |
| Debt to Equity Ratio | 0.2324 |
| Current Ratio | 3.516 |
| Net Debt Paydown Yield | -1.56% |